|
|
|
Sunday, March 25, 2007 - 7:30 PM, Manchester A - C
|
- Molecular Classification of Cancer: Practical Applications for the Surgical Pathologist
|
|
Moderator:
|
Karen E. Weck, University of North Carolina, Chapel Hill, NC
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Mark Erlander indicated he is an employee at Aviaradx. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to download handout in 1-per-page format for the entire meeting
Click here to download handout in 6-per-page format for the entire meeting
Click any blue title below to display and print the handout for individual lecture(s):
| 7:30 | Introduction - Karen E. Weck, University of North Carolina, Chapel Hill, NC |
| 7:45 | Molecular Classification of Breast Cancer: From Microarrays to Clinical Lab Testing - Philip Bernard, University of Utah, Salt Lake City, UT |
| 8:20 | Molecular Classification of Cancer: Implications for Carcinoma of Unknown Primary - Mark Erlander, AviaraDx, Inc., Carlsbad, CA |
| 8:55 | Microsatellite Instability Testing in Colon Cancer: The Role of the Pathologist - Antonia Sepulveda, University of Pittsburgh Medical Center, Pittsburgh, PA |
| The objective of this symposia is to provide practical knowledge in molecular testing of cancer that is applicable to surgical pathology practices. Current advances in molecular pathology are changign the practice of pathology and pathologists need to know what molecular tools are available to help in diagnosis and classification of cancer, when molecular tests may be useful, and how to order and interpret these tests. Topics were chosen based on recent developments in molecular diagnostics that have the potential to affect the practice of surgical pathology or that are already changing practice. |
|
|
|
